ID   A549/8
AC   CVCL_IY87
DR   cancercelllines; CVCL_IY87
DR   Wikidata; Q54607043
RX   PubMed=94594;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 10
//
RX   PubMed=94594; DOI=10.1002/ijc.2910240622;
RA   Edgell C.-J.S., Gazdar A.F., Minna J.D.;
RT   "Expression of feline xenotropic RNA tumor virus in hybrids between
RT   permissive human and non-permissive mouse cells.";
RL   Int. J. Cancer 24:826-834(1979).
//